Complement inhibitor therapy in atypical hemolytic uremic syndrome (aHUS): evaluating the economic impact of introducing eculizumab biosimilars in Germany. [PDF]
Kaufhold I +4 more
europepmc +1 more source
Evaluation of Hypertension in Pediatric Hemolytic Uremic Syndrome (A Cross-Sectional Study). [PDF]
Nourmohammadi MB +5 more
europepmc +1 more source
Atypical Hemolytic Uremic Syndrome in Children and Adults With the Hot Spot C3 Gene Variant p.Arg161Trp. [PDF]
Ter Steeg L +23 more
europepmc +1 more source
Pregnancy-Associated Atypical Hemolytic Uremic Syndrome With Kidney Recovery Despite Delayed Initiation of Complement Blockade. [PDF]
Hamadah A +6 more
europepmc +1 more source
Hemoglobinuria-associated acute kidney injury in hemolytic uremic syndrome without renal thrombotic microangiopathy. [PDF]
Mancianti N +4 more
europepmc +1 more source
Complement-targeted therapies for C3 glomerulopathy and atypical hemolytic uremic syndrome: a time-limited rapid systematic review with narrative synthesis. [PDF]
Wu Q, Yu Z, Wu Z, Yang L, Lin X.
europepmc +1 more source
Severe leptospirosis complicated by atypical hemolytic uremic syndrome, myocarditis, and acute liver injury: a therapeutic challenge-a case report and review of the literature. [PDF]
Nmm R, Ik J, N A, Kad W, Jf S.
europepmc +1 more source
Response to the Letter to the Editor Entitled "Defining "Dominance" in Atypical Hemolytic Uremic Syndrome: Distinguishing Amplification From Initiation". [PDF]
Aiello S +5 more
europepmc +1 more source
Treatment of atypical hemolytic uremic syndrome and C3 glomerulopathy in mice by hepatic expression of factor D. [PDF]
Kim H +6 more
europepmc +1 more source
Pediatric Hemolytic Uremic Syndrome in North-Eastern Germany During the STEC O45:H2 Outbreak in 2025: Clinical Features and Short-Term Outcomes. [PDF]
Merz LM +21 more
europepmc +1 more source

